More countries have followed Denmark by suspending approval of the AstraZeneca jab. Norway, Denmark, Estonia, Lithuania, Luxembourg, Latvia, and Italy have now opted to halt use of the injection, creating more problems for Europe’s sluggish jab roll-out.
